BANGKOK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a tech-forward, diversified, multi-jurisdictional entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced that it intends to execute its previously authorized share repurchase program initially announced on November 10, 2025 through The Benchmark Company, LLC (“Benchmark”), a subsidiary o ...

Core Viewpoint - NewGenIVF Group Limited has been initiated for equity research coverage by Zacks Small-Cap Research, highlighting its potential in various high-growth sectors [1]. Group 1: Company Overview - NewGenIVF Group is a diversified, tech-forward entity focusing on real estate development, digital asset management, and reproductive health solutions [2]. - The company operates through three strategic divisions: NewGenProperty (real estate in UAE), NewGenDigital (digital asset and DeFi solutions), and NewGenSup (health and longevity products) [2]. - NewGenIVF Group has a legacy in providing IVF and assisted reproductive treatment services across Asia, positioning it uniquely in the market [2]. Group 2: Market Positioning - The company leverages cutting-edge technology and innovative solutions to drive sustainable growth and high returns on investment for shareholders [2]. - NewGenIVF Group is strategically positioned to capitalize on the convergence of real estate, healthcare, and digital asset opportunities in the evolving global economy [2].